Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis.

Authors
Zhang-G; Panigrahy-D; Hwang-SH; Yang-J; Mahakian-LM; Wettersten-HI; Liu-J-Y; Wang-Y; Ingham-ES; Tam-S; Kieran-MW; Weiss-RH; Ferrara-KW; Hammock-BD
Source
Proc Natl Acad Sci U.S.A. 2014 Jul; 111(30):11127-11132
NIOSHTIC No.
20044747
Abstract
Prostaglandins derived from the cyclooxygenase (COX) pathway and epoxyeicosatrienoic acids (EETs) from the cytochrome P450/soluble epoxide hydrolase (sEH) pathway are important eicosanoids that regulate angiogenesis and tumorigenesis. COX-2 inhibitors, which block the formation of prostaglandins, suppress tumor growth, whereas sEH inhibitors, which increase endogenous EETs, stimulate primary tumor growth and metastasis. However, the functional interactions of these two pathways in cancer are unknown. Using pharmacological inhibitors as probes, we show here that dual inhibition of COX-2 and sEH synergistically inhibits primary tumor growth and metastasis by suppressing tumor angiogenesis. COX-2/sEH dual pharmacological inhibitors also potently suppress primary tumor growth and metastasis by inhibiting tumor angiogenesis via selective inhibition of endothelial cell proliferation. These results demonstrate a critical interaction of these two lipid metabolism pathways on tumorigenesis and suggest dual inhibition of COX-2 and sEH as a potential therapeutic strategy for cancer therapy.
Keywords
Pharmaceuticals; Pharmacodynamics; Tumors; Tumor-inhibition; Prostaglandin-inhibitors; Cytochemistry; Cytology; Cytopathology; Enzyme-activity; Enzymes; Acids; Fatty-acids; Tumorigenesis; Synergism; Cancer; Cell-alteration; Cellular-reactions; Lipids; Cell-metabolism; Disease-control
Contact
Bruce D. Hammock, Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, CA 95616
CODEN
PNASA6
Publication Date
20140714
Document Type
Journal Article
Email Address
bdhammock@ucdavis.edu
Funding Type
Cooperative Agreement
Fiscal Year
2014
NTIS Accession No.
NTIS Price
Identifying No.
Cooperative-Agreement-Number-U50-OH-007550; M072014
Issue of Publication
30
ISSN
0027-8424
Source Name
Proceedings of the National Academy of Sciences of the United States of America
State
MA; CA
Performing Organization
University of California - Davis
TOP